Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study*

@article{Cooper2006TreatmentPW,
  title={Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study*},
  author={Alyse Cooper and Joan Drake and Eamonn Brankin},
  journal={International Journal of Clinical Practice},
  year={2006},
  volume={60},
  pages={896 - 905}
}
Osteoporosis is a common and debilitating condition associated with significant morbidity and mortality. The efficacy and safety of oral bisphosphonates for the treatment of osteoporosis are well established. However, patient adherence and persistence on treatment are suboptimal. This randomised open-label multi-centre study of 6-months' duration compared persistence on treatment in postmenopausal women with osteoporosis receiving either once-monthly ibandronate plus a patient support programme… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Adherence to bisphosphonate therapy is associated with decreased nonvertebral osteoporotic fracture risk

S Silverman, E Siris, T Abbott
J Bone Miner Res 2005; • 2005

Assessment of Adherence and Persistence with Daily and Weekly Dosing Regimens of Oral Bisphosphonates

SJ Boccuzzi, SH Folz, KH Kahler
2005

Impact on non - compliance and non - persistence with daily bisphosphonates on longer - term effectiveness outcomes in patients with osteoporosis treated in tertiary specialist care

RA Yood, S Emani, JI Reed
J Bone Miner Res • 2004

Similar Papers

Loading similar papers…